Stefan Cross serves as Executive at HedgePath Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Stefan Cross has executed 3 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Dec 19, 2017 involved purchasing 600,000 shares valued at $0.
Stefan Cross currently holds 600,000 shares of HedgePath Pharmaceuticals, Inc. (HPPI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Stefan Cross has been a net neutral trader of HPPI stock. They have purchased $0 and sold $0 worth of shares.
Stefan Cross's most recent insider trade was on Dec 19, 2017, when they purchased 600,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Mar 8, 2017 | HPPI | $0 | Option Exercise | 300,000 | $N/A | Discretionary |